Management of disseminated intravascular coagulation.
Disseminated intravascular coagulation (DIC) is a complex condition in which diffuse clotting and profuse hemorrhaging occur simultaneously. It is a serious, often fatal, condition that is estimated to occur in approximately 10% of all patients diagnosed with cancer. No single laboratory test is available that is absolutely diagnostic for DIC; however, several laboratory results, combined with certain clinical findings, will support the diagnosis. Despite the lack of a standardized protocol for clinical management, aggressive medical and nursing care can play a prominent role in the clinical outcome of the patient with DIC.
Maxson
J H
JH
Women's Surgical Oncology, University Hospitals of Cleveland, Frances Payne Bolton School of Nursing, Case Western Reserve University, Cleveland, Ohio, USA.
D000925:Anticoagulants / Q000627:therapeutic use; D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D003422:Critical Care / Q000379:methods; D004211:Disseminated Intravascular Coagulation / Q000097:blood / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D005342:Fibrinolysis / Q000502:physiology; D006487:Hemostasis / Q000502:physiology; D006801:Humans; D009369:Neoplasms / Q000150:complications; D009730:Nursing Assessment / Q000379:methods; D009859:Oncology Nursing / Q000379:methods; D010347:Patient Care Planning
D000925:Anticoagulants; D000933:Antifibrinolytic Agents